Cover Image
市場調查報告書

Bio3 Research S.r.l:產品平台分析

Bio3 Research S.r.l - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 226250
出版日期 內容資訊 英文 24 Pages
訂單完成後即時交付
價格
Back to Top
Bio3 Research S.r.l:產品平台分析 Bio3 Research S.r.l - Product Pipeline Review - 2015
出版日期: 2015年03月11日 內容資訊: 英文 24 Pages
簡介

Bio3 Research S.r.l 是鑑定HMGB1蛋白質的特質,致力於其過剩表現相關疾病的治療藥開發的生物製藥公司。該公司還有在心血管和腎臟學、組織再生的領域開發有療效性的獨特化合物。該公司不與外部機關合作獨自進行研究開發。

本報告提供Bio3 Research S.r.l的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

Bio3 Research S.r.l基本資料

  • Bio3 Research S.r.l概要
  • 主要資訊
  • 企業資料

Bio3 Research S.r.l:R&D概要

  • 主要的治療範圍

Bio3 Research S.r.l:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Bio3 Research S.r.l:開發中產品概況

  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Bio3 Research S.r.l:藥物簡介

  • CTR-1
  • CTR-2
  • CTR-3
  • CT-406
  • CTR-4

Bio3 Research S.r.l:開發平台分析

  • 各標靶
  • 各分子類型
  • 各作用機制

Bio3 Research S.r.l:最近的開發平台趨勢

Bio3 Research S.r.l:暫停中的計劃

Bio3 Research S.r.l:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06842CDB

Summary

Global Markets Direct's, 'Bio3 Research S.r.l - Product Pipeline Review - 2015', provides an overview of the Bio3 Research S.r.l's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Bio3 Research S.r.l's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Bio3 Research S.r.l including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Bio3 Research S.r.l's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Bio3 Research S.r.l's pipeline products

Reasons to buy

  • Evaluate Bio3 Research S.r.l's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Bio3 Research S.r.l in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Bio3 Research S.r.l's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Bio3 Research S.r.l and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Bio3 Research S.r.l
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Bio3 Research S.r.l and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Bio3 Research S.r.l Snapshot
    • Bio3 Research S.r.l Overview
    • Key Information
    • Key Facts
  • Bio3 Research S.r.l - Research and Development Overview
    • Key Therapeutic Areas
  • Bio3 Research S.r.l - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Bio3 Research S.r.l - Pipeline Products Glance
    • Bio3 Research S.r.l - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Bio3 Research S.r.l - Drug Profiles
    • CTR-1
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CTR-2
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CTR-3
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CT-406
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CTR-4
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Bio3 Research S.r.l - Pipeline Analysis
    • Bio3 Research S.r.l - Pipeline Products by Target
    • Bio3 Research S.r.l - Pipeline Products by Molecule Type
    • Bio3 Research S.r.l - Pipeline Products by Mechanism of Action
  • Bio3 Research S.r.l - Recent Pipeline Updates
  • Bio3 Research S.r.l - Dormant Projects
  • Bio3 Research S.r.l - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Bio3 Research S.r.l, Key Information
  • Bio3 Research S.r.l, Key Facts
  • Bio3 Research S.r.l - Pipeline by Indication, 2015
  • Bio3 Research S.r.l - Pipeline by Stage of Development, 2015
  • Bio3 Research S.r.l - Monotherapy Products in Pipeline, 2015
  • Bio3 Research S.r.l - Preclinical, 2015
  • Bio3 Research S.r.l - Discovery, 2015
  • Bio3 Research S.r.l - Pipeline by Target, 2015
  • Bio3 Research S.r.l - Pipeline by Molecule Type, 2015
  • Bio3 Research S.r.l - Pipeline Products by Mechanism of Action, 2015
  • Bio3 Research S.r.l - Recent Pipeline Updates, 2015
  • Bio3 Research S.r.l - Dormant Developmental Projects,2015
  • Bio3 Research S.r.l, Subsidiaries

List of Figures

  • Bio3 Research S.r.l - Pipeline by Top 10 Indication, 2015
  • Bio3 Research S.r.l - Pipeline by Stage of Development, 2015
  • Bio3 Research S.r.l - Monotherapy Products in Pipeline, 2015
  • Bio3 Research S.r.l - Pipeline by Top 10 Target, 2015
  • Bio3 Research S.r.l - Pipeline by Top 10 Molecule Type, 2015
  • Bio3 Research S.r.l - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top